Quest Diagnostics Incorporated (DGX)

Quest Diagnostics (NYSE: DGX) Signs Agreement To Sequence COVID-19 Gene Variants

Quest Diagnostics Incorporated (NYSE: DGX) has signed a contract with CDC to give genomic sequencing to recognize new mutations in and patterns of transmission of SARS-CoV-2.